Literature DB >> 12783433

Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.

Mario H J Vogt1, Luba Lopatinskaya, Monique Smits, Chris H Polman, Lex Nagelkerken.   

Abstract

In the search for proteins that might play a role in the pathogenesis of multiple sclerosis (MS), osteopontin (OPN) has been identified as the most prominent cytokine-encoding gene expressed within MS lesions. Here, we report significantly increased OPN protein levels in plasma of relapsing-remitting MS patients. In contrast, OPN protein levels in primary progressive and secondary progressive MS patients were similar to healthy control levels. Interestingly, active relapsing-remitting patients had higher OPN protein levels than patients without relapses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783433     DOI: 10.1002/ana.10606

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  37 in total

Review 1.  Intracellular osteopontin (iOPN) and immunity.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 2.  A molecular trio in relapse and remission in multiple sclerosis.

Authors:  Lawrence Steinman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

3.  Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event.

Authors:  Jean-Christophe Corvol; Daniel Pelletier; Roland G Henry; Stacy J Caillier; Joanne Wang; Derek Pappas; Simona Casazza; Darin T Okuda; Stephen L Hauser; Jorge R Oksenberg; Sergio E Baranzini
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-08       Impact factor: 11.205

4.  Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea.

Authors:  Taichang Jang; Todd Savarese; Hoi Pang Low; Sunchin Kim; Hannes Vogel; David Lapointe; Timothy Duong; N Scott Litofsky; James M Weimann; Alonzo H Ross; Lawrence Recht
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

5.  Mixed results with modulation of TH-17 cells in human autoimmune diseases.

Authors:  Lawrence Steinman
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

6.  Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.

Authors:  Takashi Nomiyama; Diego Perez-Tilve; Daisuke Ogawa; Florence Gizard; Yue Zhao; Elizabeth B Heywood; Karrie L Jones; Ryuzo Kawamori; Lisa A Cassis; Matthias H Tschöp; Dennis Bruemmer
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

Review 7.  Nuanced roles of cytokines in three major human brain disorders.

Authors:  Lawrence Steinman
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

Review 8.  Genetic associations in type I interferon related pathways with autoimmunity.

Authors:  Angélica M Delgado-Vega; Marta E Alarcón-Riquelme; Sergey V Kozyrev
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

Review 9.  Chipping away at diagnostics for neurodegenerative diseases.

Authors:  Clemens R Scherzer
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

10.  Early over expression of messenger RNA for multiple genes, including insulin, in the Pancreatic Lymph Nodes of NOD mice is associated with Islet Autoimmunity.

Authors:  Béatrice Regnault; José Osorio Y Fortea; Dongmei Miao; George Eisenbarth; Evie Melanitou
Journal:  BMC Med Genomics       Date:  2009-10-02       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.